BookmarkBEIJING: Indonesia said on Monday (Apr 12) that it is satisfied with the effectiveness of the Sinovac coronavirus vaccine it is using, after the acknowledgement by China’s top disease control official that current vaccines offer low protection against the virus.
Siti Nadia Tarmizi, a spokesperson for Indonesia’s COVID-19 vaccine programme, said the World Health Organization had found the Chinese vaccines had met requirements by being more than 50 per cent effective. She noted that clinical trials for the Sinovac vaccine in Indonesia showed it was 65 per cent effective.
AdvertisementAdvertisement“It means we are talking about the ability to form antibodies in our bodies is still very good,” she said.Gao Fu, the head of the Chinese Center for Disease Control and Prevention, said at a conference Saturday that existing COVID-19 vaccines had low effectiveness rates and headtopics.com
mixing vaccines is among strategies being consideredto boost their effectiveness.Those comments appeared to running counter to China's official narrative that has tried to promote the country’s vaccines and at times discredit its Western counterparts.
China has distributed hundreds of millions of doses of domestically made vaccines abroad and is relying on them for its own mass immunisation campaign.AdvertisementAdvertisementTarmizi said Indonesia would wait to see the results of any clinical trials before considering mixing vaccines.
“We are going to wait, waiting for the clinical trial to ensure the idea or innovation will have better effectiveness, immunogenicity, and efficacy level compared to the current condition,” she said. Read more: CNA »
Triad Trails: Former secret society members lead tour on Chinatown’s seedy past
SINGAPORE — Pointing to a row of shophouses along Pagoda Street leading up to Chinatown MRT Station, a heavily-tattooed man tells the group behind him that the shops used to be opium dens in the 19th century.